-
European Journal of Nuclear Medicine... Aug 2021Nuclear medicine parathyroid imaging is important in the identification of hyperfunctioning parathyroid glands in primary hyperparathyroidism (pHPT), but it may be also...
INTRODUCTION
Nuclear medicine parathyroid imaging is important in the identification of hyperfunctioning parathyroid glands in primary hyperparathyroidism (pHPT), but it may be also valuable before surgical treatment in secondary hyperparathyroidism (sHPT). Parathyroid radionuclide imaging with scintigraphy or positron emission tomography (PET) is a highly sensitive procedure for the assessment of the presence and number of hyperfunctioning parathyroid glands, located either at typical sites or ectopically. The treatment of pHPT is mostly directed toward minimally invasive parathyroidectomy, especially in cases with a single adenoma. In experienced hands, successful surgery depends mainly on the exact preoperative localization of one or more hyperfunctioning parathyroid adenomas. Failure to preoperatively identify the hyperfunctioning parathyroid gland challenges minimally invasive parathyroidectomy and might require bilateral open neck exploration.
METHODS
Over a decade has now passed since the European Association of Nuclear Medicine (EANM) issued the first edition of the guideline on parathyroid imaging, and a number of new insights and techniques have been developed since. The aim of the present document is to provide state-of-the-art guidelines for nuclear medicine physicians performing parathyroid scintigraphy, single-photon emission computed tomography/computed tomography (SPECT/CT), positron emission tomography/computed tomography (PET/CT), and positron emission tomography/magnetic resonance imaging (PET/MRI) in patients with pHPT, as well as in those with sHPT.
CONCLUSION
These guidelines are written and authorized by the EANM to promote optimal parathyroid imaging. They will assist nuclear medicine physicians in the detection and correct localization of hyperfunctioning parathyroid lesions.
Topics: Humans; Hyperparathyroidism, Primary; Nuclear Medicine; Parathyroid Glands; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi
PubMed: 33839893
DOI: 10.1007/s00259-021-05334-y -
JACC. Cardiovascular Imaging Jun 2020Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with a median survival from diagnosis, if untreated, ranging from <6 months for... (Review)
Review
Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with a median survival from diagnosis, if untreated, ranging from <6 months for light chain amyloidosis to 3 to 5 years for transthyretin amyloidosis. Early diagnosis and accurate typing of CA are necessary for optimal management of these patients. Emerging novel disease modifying therapies increase the urgency to diagnose CA at an early stage and identify patients who may benefit from these life-saving therapies. The goal of this review is to provide a practical approach to echocardiography, cardiac magnetic resonance, and radionuclide imaging in patients with known or suspected CA.
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Early Diagnosis; Echocardiography; Humans; Immunoglobulin Light-chain Amyloidosis; Magnetic Resonance Imaging; Predictive Value of Tests; Radionuclide Imaging; Reproducibility of Results
PubMed: 31607664
DOI: 10.1016/j.jcmg.2019.07.015 -
Journal of Nuclear Medicine : Official... Sep 2019In this article, we provide an overview of established and emerging conventional nuclear medicine and PET imaging biomarkers, as the diagnostic nuclear medicine... (Review)
Review
In this article, we provide an overview of established and emerging conventional nuclear medicine and PET imaging biomarkers, as the diagnostic nuclear medicine portfolio is rapidly expanding. Next, we review briefly nuclear theranostic approaches that have already entered or are about to enter clinical routine. Using some approximations and taking into account emerging applications, we also provide some simplified business forecasts for nuclear theranostics. We argue that an optimistic outlook by the nuclear medicine community is crucial to the growth of the specialty and emphasize the urgent need for training adaptations.
Topics: Biomarkers; Forecasting; Humans; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Specialization
PubMed: 31481589
DOI: 10.2967/jnumed.118.220558 -
Journal of the American College of... Jun 2020Technetium-labeled cardiac scintigraphy (i.e., Tc-PYP scan) has been repurposed for the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). Validated in cohorts... (Review)
Review
Technetium-labeled cardiac scintigraphy (i.e., Tc-PYP scan) has been repurposed for the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). Validated in cohorts of patients with heart failure and echocardiographic and/or cardiac magnetic resonance imaging findings suggestive of cardiac amyloidosis, cardiac scintigraphy can confirm the diagnosis of ATTR-CM only when combined with blood and urine testing to exclude a monoclonal protein. Multisocietal guidelines support the nonbiopsy diagnosis of ATTR-CM using cardiac scintigraphy, yet emphasize its use in the appropriate clinical context and the crucial need to rule out light chain amyloid cardiomyopathy. Although increased awareness of ATTR-CM and the advent of effective therapy have led to rapid adoption of diagnostic scintigraphy, there is heterogeneity in adherence to consensus guidelines. This perspective outlines clinical scenarios wherein findings on technetium-labeled cardiac scintigraphy have been misinterpreted, reviews causes of false-negative and false-positive results, and provides strategies to avoid costly and potentially fatal misdiagnoses.
Topics: Amyloidosis; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cardiomyopathies; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Organotechnetium Compounds; Radioactive Tracers; Radionuclide Imaging; Technetium
PubMed: 32498813
DOI: 10.1016/j.jacc.2020.04.022 -
Methods in Molecular Biology (Clifton,... 2021The purpose of this Chapter is to present a detailed description of methods for performing bone Micro-Computed Tomography (microCT) scanning and analysis. MicroCT is an...
The purpose of this Chapter is to present a detailed description of methods for performing bone Micro-Computed Tomography (microCT) scanning and analysis. MicroCT is an x-ray imaging method capable of visualizing bone at the micro-structural scale, that is, 1-100 µm resolution. MicroCT is the gold-standard method for assessment of 3D bone morphology in studies of small animals. As applied to the small bones of mice or rats, microCT can efficiently and accurately assess bone structure (e.g., cortical bone area [Ct.Ar]) and micro-structure (e.g., trabecular bone volume fraction [Tb.BV/TV]). The particular application described herein is for post mortem mouse femur specimens. The material presented should be generally applicable to many commercially available laboratory microCT systems, although some details are specific to the system used in our lab (Scanco mCT 40; SCANCO Medical AG, Bruttisellen, Switzerland).
Topics: Animals; Bone Density; Femur; Humans; Image Processing, Computer-Assisted; Mice; Radionuclide Imaging; Skull; Tibia; X-Ray Microtomography
PubMed: 33197015
DOI: 10.1007/978-1-0716-1028-2_11 -
Circulation. Cardiovascular Imaging Jul 2021
Review
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.
Topics: Amyloidosis; Biopsy; Cardiomyopathies; Consensus; Echocardiography; Evidence-Based Medicine; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Myocardium; Predictive Value of Tests; Prognosis; Radionuclide Imaging
PubMed: 34196223
DOI: 10.1161/HCI.0000000000000029 -
Cardiology Clinics May 2023The heart and brain have a complex interplay wherein disease or injury to either organ may adversely affect the other. The mechanisms underlying this connection remain... (Review)
Review
The heart and brain have a complex interplay wherein disease or injury to either organ may adversely affect the other. The mechanisms underlying this connection remain incompletely characterized. However, nuclear molecular imaging is uniquely suited to investigate these pathways by facilitating the simultaneous assessment of both organs using targeted radiotracers. Research within this paradigm has demonstrated important roles for inflammation, autonomic nervous system and neurohormonal activity, metabolism, and perfusion in the heart-brain connection. Further mechanistic clarification may facilitate greater clinical awareness and the development of targeted therapies to alleviate the burden of disease in both organs.
Topics: Humans; Heart; Radionuclide Imaging; Heart Failure; Brain; Positron-Emission Tomography
PubMed: 37003682
DOI: 10.1016/j.ccl.2023.01.013 -
BMC Musculoskeletal Disorders Feb 2021In recent years, technological improvements allowed imaging modalities to become increasingly essential in achieving early and precise diagnoses in the field of...
In recent years, technological improvements allowed imaging modalities to become increasingly essential in achieving early and precise diagnoses in the field of rheumatic and musculoskeletal diseases (RMDs). To date, imaging examinations are routinely used in all steps of diagnostic and therapeutic care pathways of patients affected by RMDs. The articles published in this Article Collection clearly show the efforts of researchers to find innovative applications of musculoskeletal imaging in clinical practice and to face the crucial challenges that remain in the interpretation and quality control of images. Highly performing diagnostic technologies are currently available to early diagnose and accurately monitor several musculoskeletal disorders, but also to guide personalized interventional therapeutic procedures tailored to the individual patients in the emerging process of precision medicine. Among these new modalities, some are particularly promising and thereby subject to several lines of research in RMDs, including SPECT-CT and dual-energy CT, MRI sequences, high and ultra-high frequency ultrasound with effective tools like shear wave elastography.
Topics: Elasticity Imaging Techniques; Humans; Magnetic Resonance Imaging; Musculoskeletal Diseases; Radionuclide Imaging; Ultrasonography
PubMed: 33641666
DOI: 10.1186/s12891-021-04101-2 -
European Journal of Nuclear Medicine... Mar 2022Apoptosis was a natural, non-inflammatory, energy-dependent form of programmed cell death (PCD) that can be discovered in a variety of physiological and pathological... (Review)
Review
Apoptosis was a natural, non-inflammatory, energy-dependent form of programmed cell death (PCD) that can be discovered in a variety of physiological and pathological processes. Based on its characteristic biochemical changes, a great number of apoptosis probes for single-photon emission computed tomography (SPECT) and positron emission tomography (PET) have been developed. Radionuclide imaging with these tracers were potential for the repetitive and selective detection of apoptotic cell death in vivo, without the need for invasive biopsy. In this review, we overviewed molecular mechanism and specific biochemical changes in apoptotic cells and summarized the existing tracers that have been used in clinical trials as well as their potentialities and limitations. Particularly, we highlighted the clinic applications of apoptosis imaging as diagnostic markers, early-response indicators, and prognostic predictors in multiple disease fields.
Topics: Apoptosis; Humans; Positron-Emission Tomography; Radionuclide Imaging; Tomography, Emission-Computed, Single-Photon
PubMed: 34873639
DOI: 10.1007/s00259-021-05641-4 -
Journal of Medical Radiation Sciences Apr 2023Conventional radiomics in nuclear medicine involve hand-crafted and computer-assisted regions of interest. Recent developments in artificial intelligence (AI) have seen... (Review)
Review
Conventional radiomics in nuclear medicine involve hand-crafted and computer-assisted regions of interest. Recent developments in artificial intelligence (AI) have seen the emergence of AI-augmented segmentation and extraction of lower order traditional radiomic features. Deep learning (DL) affords the opportunity to extract abstract radiomic features directly from input tensors (images) without the need for segmentation. These fourth-order, high dimensional radiomics produce deep radiomics and are well suited to the data density associated with the molecular nature of hybrid imaging. Molecular radiomics and deep molecular radiomics provide insights beyond images and quantitation typical of semantic reporting. While the application of molecular radiomics using hand-crafted and computer-generated features is integrated into decision-making in nuclear medicine, the acceptance of deep molecular radiomics is less universal. This manuscript aims to provide an understanding of the language and principles associated with radiomics and deep radiomics in nuclear medicine.
Topics: Artificial Intelligence; Diagnostic Imaging; Radionuclide Imaging
PubMed: 36238997
DOI: 10.1002/jmrs.626